Shuai Leng
-
- Cancer, Hypoxia, and Metabolism 2
-
- Epigenetics and DNA Methylation 7
- Cancer-related gene regulation 5
- RNA modifications and cancer 4
- Histone Deacetylase Inhibitors Research 3
-
- Moyamoya disease diagnosis and treatment 2
-
- Metastasis and carcinoma case studies 2
-
- Autophagy in Disease and Therapy 1
- Co-authors
- Wei HuangDandan FengYan WangYang YangRuiqiong LiuRongfang QiuYi ZengYongqiang Hou
- Journals
- Nucleic Acids Research (1 paper)Journal of Biological Chemistry (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Shuai Leng
13 papers receiving 424 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 97
- Molecular Biology 354
- Geriatrics and Gerontology 17
- Oncology 83
- Immunology 33
Countries citing papers authored by Shuai Leng
This map shows the geographic impact of Shuai Leng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Leng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Leng more than expected).
Fields of papers citing papers by Shuai Leng
This network shows the impact of papers produced by Shuai Leng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Leng. The network helps show where Shuai Leng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuai Leng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2021 | 46 | |
| 4 | 2021 | 21 | |
| 5 | 2021 | 36 | |
| 6 | 2019 | 57 | |
| 7 | 2019 | 28 | |
| 8 | 2019 | 21 | |
| 9 | BRMS1 coordinates with LSD1 and suppresses breast cancer cell metastasis. | 2018 | 23 |
| 10 | 2018 | 30 | |
| 11 | 2018 | 56 | |
| 12 | 2018 | 72 | |
| 13 | 2014 | 31 |
About Shuai Leng
Shuai Leng is a scholar working on Physiology, Geriatrics and Gerontology and Cancer Research, having authored 13 papers that have together received 427 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), Cancer-related gene regulation (5 papers), RNA modifications and cancer (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Moyamoya disease diagnosis and treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Metastasis and carcinoma case studies (2 papers) and Autophagy in Disease and Therapy (1 paper). The work is most often cited by research in Cancer Research (97 citations), Molecular Biology (354 citations) and Geriatrics and Gerontology (17 citations). Shuai Leng has collaborated with scholars based in China and United States. Frequent co-authors include Wei Huang, Dandan Feng, Yan Wang, Yang Yang, Ruiqiong Liu, Rongfang Qiu, Yi Zeng, Yongqiang Hou, Jie Gao and Yu Zheng. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.